Moreover, high SOX2 levels resulted in 48% risk reduction in NSCLC patients at Cox proportional univariate analysis (hazards ratio-HR = 0.52 confidence interval-CI (0.36,0.73), p = 0.0002). Here, SOX2 is linked to non-small cell lung carcinoma.